Basit öğe kaydını göster

dc.contributor.authorLutz, P
dc.contributor.authorCasanova, JL
dc.contributor.authorCamcioglu, Y
dc.contributor.authorDonnadieu, J
dc.contributor.authorLandman-Parker, J
dc.contributor.authorAkcakaya, N
dc.contributor.authorCokugras, H
dc.contributor.authorBordigoni, P
dc.contributor.authorJouanguy, E
dc.contributor.authorDupuis, S
dc.contributor.authorPallier, A
dc.contributor.authorDoffinger, R
dc.contributor.authorFondaneche, MC
dc.contributor.authorFieschi, C
dc.contributor.authorLamhamedi-Cherradi, S
dc.contributor.authorAltare, F
dc.contributor.authorEmile, JF
dc.date.accessioned2021-03-03T20:19:05Z
dc.date.available2021-03-03T20:19:05Z
dc.date.issued2000
dc.identifier.citationJouanguy E., Dupuis S., Pallier A., Doffinger R., Fondaneche M., Fieschi C., Lamhamedi-Cherradi S., Altare F., Emile J., Lutz P., et al., "In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma", JOURNAL OF CLINICAL INVESTIGATION, cilt.105, sa.10, ss.1429-1436, 2000
dc.identifier.issn0021-9738
dc.identifier.othervv_1032021
dc.identifier.otherav_594c11f9-55f2-444d-8ba4-551cb186b634
dc.identifier.urihttp://hdl.handle.net/20.500.12627/62833
dc.identifier.urihttps://doi.org/10.1172/jci9166
dc.description.abstractComplete IFN-gamma receptor ligand-binding chain (IFN gamma R1) deficiency is a life-threatening autosomal recessive immune disorder, Affected children invariably die of mycobacterial infection, unless bone marrow transplantation is undertaken. Pathogenic IFNGR1 mutations identified to date include nonsense and splice mutations and frameshift deletions and insertions. All result in a premature stop codon upstream from the segment encoding the transmembrane domain, precluding cell surface expression of the receptors, We report herein two sporadic and two familial cases of a novel form of complete IFN gamma R1 deficiency in which normal numbers of receptors are detected at the cell surface. Two in-frame deletions and two missense IFNGR1 mutations were identified in the segment encoding the extracellular ligand-binding domain of the receptor. Eight independent IFN gamma R1-specific mAb's, including seven blocking antibodies, gave recognition patterns that differed between patients, suggesting that different epitopes were altered by the mutations. No specific binding of I-125-IFN-gamma to cells was observed in any patient, however, and the cells failed to respond to IFN-gamma. The mutations therefore cause complete IFN gamma R1 deficiency by disrupting the IFN-gamma-binding site without affecting surface expression, The detection of surface IFN gamma R1 molecules by specific antibodies, including blocking antibodies, does not exclude a diagnosis of complete IFN gamma R1 deficiency.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.titleIn a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL INVESTIGATION
dc.contributor.department, ,
dc.identifier.volume105
dc.identifier.issue10
dc.identifier.startpage1429
dc.identifier.endpage1436
dc.contributor.firstauthorID125701


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster